紫藤根提取物对实验性大鼠良性前列腺增生氧化应激的调节作用

A. Ikeyi, I. Okagu, Christiana Nonye Igwe
{"title":"紫藤根提取物对实验性大鼠良性前列腺增生氧化应激的调节作用","authors":"A. Ikeyi, I. Okagu, Christiana Nonye Igwe","doi":"10.3390/CAHD2020-08931","DOIUrl":null,"url":null,"abstract":"The existence of oxidative stress in the pathogenesis of benign prostatic hyperplasia (BPH), characterized by elevation in markers of oxidative stress/lipid peroxidation (8-hydroxyguanosine, malondialdehyde and 8-hydroxynonenal) and reduction in antioxidant status (catalase, superoxide dismutase, glutathione peroxidase and reduced glutathione) is scientifically documented. We hypothesize that a good treatment regimen for BPH should return the pro-oxidant/antioxidant status to normal; hence, pro-oxidant/antioxidant status is an indirect indicator of treatment response. In this study, the effect of crude methanol extract (CME) of Zapoteca portoricensis root and its methanol (MF) and ethyl acetate (EAF) fractions on the pro-oxidant/antioxidant status of experimentally-induced BPH was investigated. Forty-five Wistar albino rats (7 weeks, 180-200 g) used in this study were divided into nine groups (n = 5). Group 1 served as normal control. BPH was induced in groups 2-9 by daily subcutaneous administration of dihydrotestosterone (400 μg/ml) and estradiol (80 μg/ml) for 28 days. Group 2 served as BPH-control (was left untreated) while group 3 received dutesteride (Avodart®). Groups 4 and 5, 6 and 7, and 8 and 9 received, by gavage 200 and 400 mg/kg/d b.w. of CME, 200 and 400 mg/kg/d b.w. of MF, and 200 and 400 mg/kg/d b.w. of EAF, respectively for 14 days. There were increased prostatic specific (PSA) and malondialdehyde but reduced antioxidant status in BPH-control relative to normal control. At 400 mg/kg/d b.w, CME, MF and EAF decreased prostatic specific antigen by 55.91%, 57.54% and 56.75%, respectively comparable to 58.80% by dutesteride. In addition, the results of histological assessment of prostate tissues of the experimental rats fed extracts demonstrate an improved prostate status. The extracts returned the pro-oxidant/antioxidant status modified by BPH to normal. These findings may justify the plant’s folkloric use and suggest that extracts can be exploited further as potential source of entities for managing BPH.","PeriodicalId":199350,"journal":{"name":"Proceedings of The 1st International E-Conference on Antioxidants in Health and Disease","volume":"72 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2020-12-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Modulation of oxidative stress associated with experimentally-induced benign prostatic hyperplasia in rats by Zapoteca portoricensis root extracts\",\"authors\":\"A. Ikeyi, I. Okagu, Christiana Nonye Igwe\",\"doi\":\"10.3390/CAHD2020-08931\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The existence of oxidative stress in the pathogenesis of benign prostatic hyperplasia (BPH), characterized by elevation in markers of oxidative stress/lipid peroxidation (8-hydroxyguanosine, malondialdehyde and 8-hydroxynonenal) and reduction in antioxidant status (catalase, superoxide dismutase, glutathione peroxidase and reduced glutathione) is scientifically documented. We hypothesize that a good treatment regimen for BPH should return the pro-oxidant/antioxidant status to normal; hence, pro-oxidant/antioxidant status is an indirect indicator of treatment response. In this study, the effect of crude methanol extract (CME) of Zapoteca portoricensis root and its methanol (MF) and ethyl acetate (EAF) fractions on the pro-oxidant/antioxidant status of experimentally-induced BPH was investigated. Forty-five Wistar albino rats (7 weeks, 180-200 g) used in this study were divided into nine groups (n = 5). Group 1 served as normal control. BPH was induced in groups 2-9 by daily subcutaneous administration of dihydrotestosterone (400 μg/ml) and estradiol (80 μg/ml) for 28 days. Group 2 served as BPH-control (was left untreated) while group 3 received dutesteride (Avodart®). Groups 4 and 5, 6 and 7, and 8 and 9 received, by gavage 200 and 400 mg/kg/d b.w. of CME, 200 and 400 mg/kg/d b.w. of MF, and 200 and 400 mg/kg/d b.w. of EAF, respectively for 14 days. There were increased prostatic specific (PSA) and malondialdehyde but reduced antioxidant status in BPH-control relative to normal control. At 400 mg/kg/d b.w, CME, MF and EAF decreased prostatic specific antigen by 55.91%, 57.54% and 56.75%, respectively comparable to 58.80% by dutesteride. In addition, the results of histological assessment of prostate tissues of the experimental rats fed extracts demonstrate an improved prostate status. The extracts returned the pro-oxidant/antioxidant status modified by BPH to normal. These findings may justify the plant’s folkloric use and suggest that extracts can be exploited further as potential source of entities for managing BPH.\",\"PeriodicalId\":199350,\"journal\":{\"name\":\"Proceedings of The 1st International E-Conference on Antioxidants in Health and Disease\",\"volume\":\"72 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-12-17\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Proceedings of The 1st International E-Conference on Antioxidants in Health and Disease\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.3390/CAHD2020-08931\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Proceedings of The 1st International E-Conference on Antioxidants in Health and Disease","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3390/CAHD2020-08931","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

良性前列腺增生(BPH)的发病机制中存在氧化应激,其特征是氧化应激/脂质过氧化标志物(8-羟基鸟苷、丙二醛和8-羟基壬烯醛)升高和抗氧化状态(过氧化氢酶、超氧化物歧化酶、谷胱甘肽过氧化物酶和还原性谷胱甘肽)降低。我们假设良性前列腺增生的良好治疗方案应该使促氧化/抗氧化状态恢复正常;因此,促氧化/抗氧化状态是治疗反应的间接指标。本研究考察了紫草根粗甲醇提取物(CME)及其甲醇(MF)和乙酸乙酯(EAF)组分对实验性BPH促氧化/抗氧化状态的影响。选用Wistar白化大鼠45只(7周龄,180 ~ 200 g),随机分为9组(n = 5),第1组为正常对照。2 ~ 9组小鼠每日皮下注射双氢睾酮(400 μg/ml)和雌二醇(80 μg/ml)诱导BPH,持续28 d。2组作为bph对照组(不进行治疗),3组使用杜特雄胺(Avodart®)。第4组、第5组、第6组、第7组、第8组、第9组分别灌胃200、400 mg/kg/d日增重CME, 200、400 mg/kg/d日增重MF, 200、400 mg/kg/d日增重EAF,为期14 d。前列腺特异性(PSA)和丙二醛升高,但与正常对照相比,bph控制组抗氧化水平降低。在400 mg/kg/d b.w时,CME、MF和EAF分别降低前列腺特异性抗原55.91%、57.54%和56.75%,而dutesteride的降低率为58.80%。此外,对大鼠前列腺组织的组织学评估结果显示,大鼠的前列腺状态得到改善。提取物使BPH修饰的促氧化/抗氧化状态恢复正常。这些发现可能证明该植物的民间用途是合理的,并表明提取物可以进一步开发作为管理BPH的潜在实体来源。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Modulation of oxidative stress associated with experimentally-induced benign prostatic hyperplasia in rats by Zapoteca portoricensis root extracts
The existence of oxidative stress in the pathogenesis of benign prostatic hyperplasia (BPH), characterized by elevation in markers of oxidative stress/lipid peroxidation (8-hydroxyguanosine, malondialdehyde and 8-hydroxynonenal) and reduction in antioxidant status (catalase, superoxide dismutase, glutathione peroxidase and reduced glutathione) is scientifically documented. We hypothesize that a good treatment regimen for BPH should return the pro-oxidant/antioxidant status to normal; hence, pro-oxidant/antioxidant status is an indirect indicator of treatment response. In this study, the effect of crude methanol extract (CME) of Zapoteca portoricensis root and its methanol (MF) and ethyl acetate (EAF) fractions on the pro-oxidant/antioxidant status of experimentally-induced BPH was investigated. Forty-five Wistar albino rats (7 weeks, 180-200 g) used in this study were divided into nine groups (n = 5). Group 1 served as normal control. BPH was induced in groups 2-9 by daily subcutaneous administration of dihydrotestosterone (400 μg/ml) and estradiol (80 μg/ml) for 28 days. Group 2 served as BPH-control (was left untreated) while group 3 received dutesteride (Avodart®). Groups 4 and 5, 6 and 7, and 8 and 9 received, by gavage 200 and 400 mg/kg/d b.w. of CME, 200 and 400 mg/kg/d b.w. of MF, and 200 and 400 mg/kg/d b.w. of EAF, respectively for 14 days. There were increased prostatic specific (PSA) and malondialdehyde but reduced antioxidant status in BPH-control relative to normal control. At 400 mg/kg/d b.w, CME, MF and EAF decreased prostatic specific antigen by 55.91%, 57.54% and 56.75%, respectively comparable to 58.80% by dutesteride. In addition, the results of histological assessment of prostate tissues of the experimental rats fed extracts demonstrate an improved prostate status. The extracts returned the pro-oxidant/antioxidant status modified by BPH to normal. These findings may justify the plant’s folkloric use and suggest that extracts can be exploited further as potential source of entities for managing BPH.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信